Association of serum markers with improvement in clinical response measures after treatment with golimumab in patients with active rheumatoid arthritis despite receiving methotrexate: results from the GO-FORWARD study
2010

Serum Markers and Clinical Response to Golimumab in Rheumatoid Arthritis

Sample size: 336 publication Evidence: moderate

Author Information

Author(s): Visvanathan Sudha, Rahman Mahboob U, Keystone Edward, Genovese Mark, Klareskog Lars, Hsia Elizabeth, Mack Michael, Buchanan Jacqui, Elashoff Michael, Wagner Carrie

Primary Institution: Centocor Research and Development, Inc.

Hypothesis

The study aims to identify serum markers modulated by golimumab treatment that are associated with clinical response in rheumatoid arthritis patients.

Conclusion

Golimumab treatment leads to distinct changes in serum protein profiles that correlate with clinical response measures in rheumatoid arthritis patients.

Supporting Evidence

  • Golimumab treatment resulted in significant decreases in serum proteins compared to placebo.
  • Distinct biomarker profiles were observed in ACR 20 and ACR 50 responders.
  • Some biomarkers were associated with multiple clinical response measures.
  • The predictive values of the biomarker panel were stronger than C-reactive protein alone.

Takeaway

This study looked at blood markers in people with rheumatoid arthritis to see how they change when treated with a medicine called golimumab, helping doctors understand who might respond best to the treatment.

Methodology

Patients were randomly assigned to receive different treatments, and serum samples were collected and analyzed for various biomarkers at multiple time points.

Limitations

The small size of the training dataset may limit the reproducibility of findings in the larger test dataset.

Participant Demographics

The study included 336 patients with active rheumatoid arthritis, with a mix of treatment groups and demographics.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1186/ar3188

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication